Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma

Published:2024-03 Issue:6 Volume:59 Page:730-736
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Hu Yiting¹²³,Luo Zhongfei³,Cai Siyi³,Xie Qinfen¹²,Zheng Shusen¹²

Affiliation:

1. Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China

2. Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, Zhejiang Province, China

3. Department of Hepatobiliary and Pancreatic Surgery, Jinjiang Municipal Hospital, Quanzhou, Fujian Province, China

Funder

Science and Technology Program of Traditional Chinese Medicine in Zhejiang Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2024.2315317

Reference31 articles.

1. Hepatocellular carcinoma

2. Epigenetics in hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Hepatocellular Carcinoma

5. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma;Anti-Cancer Agents in Medicinal Chemistry;2024-08-09

2. Dual-Ligand-Modified Nanoscale Liposomes Co-Encapsulating Aspirin and Curcumin Inhibit Platelet-Induced Tumor Proliferation and Metastasis;ACS Applied Nano Materials;2024-06-07